Special Topic | Virchow in the 21st century – the Berlin Cell Hospital

Cell-based medicine has the potential to detect and counteract diseases long before symptoms become apparent. This comparatively young medical approach uses a large number of new technologies to achieve this. The Berlin Cell Hospital, which is newly…

5 Min
More

Portrait: TIB Molbiol - Test kits from Berlin detect coronaviruses around the world

From Berlin-Tempelhof to the whole world: TIB Molbiol employees developed the world’s first corona test. In the meantime, millions of people have been tested with the kits and the orders don’t stop coming in. Long-standing partner Roche recently…

3 Min
More

Charité is crowned ‘Best German Hospital 2022'

Charité retains its longstanding position at the top of the rankings.

 

3 Min
More

Golden Ticket Competition

 

Applications open

Sanofi is now accepting submissions for the 2022 Sanofi Golden Ticket Competition!

Sanofi is a global sponsor of BioLabs, a premier shared laboratory space for life science and biotech startups to test new ideas and innovate. …

2 Min
More

Combination is key – new treatments for lung and colon cancer?

Researchers from the Experimental Pharmacology and Oncology (EPO) in Berlin-Buch in cooperation with academic partners identified new experimental approaches to treat therapy resistant cancer.

Patients with advanced colon cancer have limited…

3 Min
More

Interview with Jasper Emeis, research associate of the GrOwnValve project

GrownValve is a spin-off of the Deutsches Herzzentrum Berlin and Charité. The company was founded in 2019. It develops patient-specific, endogenous heart valves, with a focus on pediatrics. We interview Jasper Emeis, research associate of GrOwnValve…

3 Min
More

​​​​​​​Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176

 

Berlin, 10 January 2022. Eckert & Ziegler Radiopharma GmbH (EZR), the radiopharmaceutical production arm of Eckert & Ziegler, has signed a joint venture and exclusive long-term supply agreements for Ytterbium-176 with Atom Mines LLC, an innovative…

2 Min
More

Imvaq Therapeutics signs a Service and Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

 

Berlin, Germany and New York, USA, January 6, 2022:

ProBioGen AG is delighted to announce the execution of a service and commercial product license agreement with Imvaq Therapeutics, a biotech company developing innovative cancer immunotherapies.…

2 Min
More

BBI Solutions completes Acquisition of BioTeZ Berlin-Buch GmbH

 

BBI Solutions, the world’s leading independent provider of immuno-diagnostic reagents and contract services, has today announced the acquisition of “Biotez”.

BioTeZ Berlin-Buch GmbH (also including Steffens Biotechnische Analysen GmbH), is a…

2 Min
More
Show more items